Net Asset Value(s)

Baronsmead VCT 3 PLC
08 December 2006

To:           RNS



Date:         8 December 2006



Company:      Baronsmead VCT 3 plc



Subject:      GlaxoSmithKline to acquire Domantis for $454m



The Board of Baronsmead VCT 3 plc is pleased to report that GlaxoSmithKline plc
(GSK) today announced that it has entered into an agreement to acquire Domantis
Ltd for US$454 million in cash.


Domantis, a privately owned company was started in 2000 by the Medical Research
Council and MVM Ltd.  Baronsmead VCT 3 plc initially invested in the company in
April 2004 and now has a total holding of £601,298.  The announcement made today
by the company represents an uplift of £1,433,286, in the net asset value
attributable to the ordinary shares of Baronsmead VCT 3 plc which equates to
4.43p per ordinary share.



For further information contact:



David Thorp, ISIS EP LLP:                            0207 506 1609

Rhonda Nicoll, F&C Asset Management plc:             0131 718 1074




                      This information is provided by RNS
            The company news service from the London Stock Exchange